News und Analysen
![Two Foolproof Plays for Apple’s Earnings: https://www.marketbeat.com/logos/articles/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHhnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e35b15b54de4d202351c0bbfb23ecdb04b180169/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg?locale=de)
Two Foolproof Plays for Apple’s Earnings
Having led much of the equity rally this year, shares of tech titan Apple Inc (NASDAQ: AAPL) have taken a hiatus in recent weeks. They managed to tag a fresh all-time high on July 19, but as they
![Two Foolproof Plays for Apple’s Earnings: https://www.marketbeat.com/logos/articles/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHhnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e35b15b54de4d202351c0bbfb23ecdb04b180169/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg?locale=de)
Two Foolproof Plays for Apple’s Earnings
Having led much of the equity rally this year, shares of tech titan Apple Inc (NASDAQ: AAPL) have taken a hiatus in recent weeks. They managed to tag a fresh all-time high on July 19, but as they
![Two Foolproof Plays for Apple’s Earnings: https://www.marketbeat.com/logos/articles/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHhnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e35b15b54de4d202351c0bbfb23ecdb04b180169/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg?locale=de)
Two Foolproof Plays for Apple’s Earnings
Having led much of the equity rally this year, shares of tech titan Apple Inc (NASDAQ: AAPL) have taken a hiatus in recent weeks. They managed to tag a fresh all-time high on July 19, but as they
![Two Foolproof Plays for Apple’s Earnings: https://www.marketbeat.com/logos/articles/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHhnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e35b15b54de4d202351c0bbfb23ecdb04b180169/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728123815_two-foolproof-plays-for-apples-earnings.jpg?locale=de)
Two Foolproof Plays for Apple’s Earnings
Having led much of the equity rally this year, shares of tech titan Apple Inc (NASDAQ: AAPL) have taken a hiatus in recent weeks. They managed to tag a fresh all-time high on July 19, but as they
![Two Value Tech Stocks Trading Near a Breakout Level: https://www.marketbeat.com/logos/articles/med_20230731120948_two-value-tech-stocks-trading-near-a-breakout-leve.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTVoYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c7744828e6a201adac530f6095691326c9753451/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230731120948_two-value-tech-stocks-trading-near-a-breakout-leve.jpg?locale=de)
Two Value Tech Stocks Trading Near a Breakout Level
In today's ever-evolving investment landscape, technology has emerged as a clear standout, surpassing the broader market with its remarkable performance year-to-date. YTD, popular technology ETF
![Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%: https://www.irw-press.at/prcom/images/messages/2023/71480/AC-310723-2.002.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90b696e65855c6b3e19b04e3b7b635c2bcd44af7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723-2.002.jpeg?locale=de)
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Software Hot Stock nach 1.855% und 6.765%
31.07.23 08:19
Vancouver (www.aktiencheck.de , Anzeige)
![Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%: https://www.irw-press.at/prcom/images/messages/2023/71480/AC-310723-2.002.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90b696e65855c6b3e19b04e3b7b635c2bcd44af7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723-2.002.jpeg?locale=de)
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Software Hot Stock nach 1.855% und 6.765%
31.07.23 08:19
Vancouver (www.aktiencheck.de , Anzeige)
![Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%: https://www.irw-press.at/prcom/images/messages/2023/71480/AC-310723-2.002.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90b696e65855c6b3e19b04e3b7b635c2bcd44af7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723-2.002.jpeg?locale=de)
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Software Hot Stock nach 1.855% und 6.765%
31.07.23 08:19
Vancouver (www.aktiencheck.de , Anzeige)
![Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%: https://www.irw-press.at/prcom/images/messages/2023/71480/AC-310723-2.002.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90b696e65855c6b3e19b04e3b7b635c2bcd44af7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723-2.002.jpeg?locale=de)
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Security Software Hot Stock nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Alto Networks, 5.252%
Börsenstar startet nach 20 Mrd. $ Erfolg diese Security Software-Aktie. Neuer Software Hot Stock nach 1.855% und 6.765%
31.07.23 08:19
Vancouver (www.aktiencheck.de , Anzeige)
![Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (: https://www.irw-press.at/prcom/images/messages/2023/71477/AC-310723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1JnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--78a234fb3a809e223766384d942f62f2bcade13e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723.001.png?locale=de)
Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (
Eilt: "Großer Sprung in der Krebsforschung" - Interview mit Prof. Dr. Rossbach. 216% Aktientip nach 15.973% mit BioNTech
31.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (: https://www.irw-press.at/prcom/images/messages/2023/71477/AC-310723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1JnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--78a234fb3a809e223766384d942f62f2bcade13e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723.001.png?locale=de)
Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (
Eilt: "Großer Sprung in der Krebsforschung" - Interview mit Prof. Dr. Rossbach. 216% Aktientip nach 15.973% mit BioNTech
31.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (: https://www.irw-press.at/prcom/images/messages/2023/71477/AC-310723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1JnYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--78a234fb3a809e223766384d942f62f2bcade13e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-310723.001.png?locale=de)
Eilt: "Großer Sprung in der Krebsforschung" - Prof. Rossbach. Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen (
Eilt: "Großer Sprung in der Krebsforschung" - Interview mit Prof. Dr. Rossbach. 216% Aktientip nach 15.973% mit BioNTech
31.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![Can SAIA Continue its Stratospheric Rally?: https://www.marketbeat.com/logos/articles/20230728103033_ismtrends.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHhmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--67e4eeb1deeb82c81a88feb3a83de463cc9ab246/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/20230728103033_ismtrends.jpg?locale=de)
Can SAIA Continue its Stratospheric Rally?
Shares of trucking and logistics giant Saia Inc. (NASDAQ: SAIA) are rising by as much as 3% during Friday's trading session, closing the week with sizeable bullish momentum in the company. The
![Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential: https://www.marketbeat.com/logos/articles/med_20230728075225_biotech-healthcare-meet-ai-stocks-soar-on-innovati.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTFmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--772cf4976c043de5cc5fd6e90251e2320e2104f4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728075225_biotech-healthcare-meet-ai-stocks-soar-on-innovati.jpg?locale=de)
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
It’s not unusual to see relatively new, unprofitable biotech stocks soaring on potential, particularly after promising clinical trial results.
But some stocks in the biotech category are rising for
![Is It Time To Buy Keurig Dr Pepper Or Cut Losses?: https://www.marketbeat.com/logos/articles/med_20230727123404_chart-kdp-7272023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTVmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7d131319a1abb3c58ac14d4e2ce1933a8d84141c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230727123404_chart-kdp-7272023.png?locale=de)
Is It Time To Buy Keurig Dr Pepper Or Cut Losses?
After correcting to long-term lows earlier this year, Keurig Dr Pepper (NASDAQ: KDP) had a beat-a-raise quarter reinvigorating the bull case. The news has shares up nearly 5% and trading at a
![3 Streaming Stocks That Can Push Past the Actors Guild Strike: https://www.marketbeat.com/logos/articles/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTlmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db0844dcd7b6675055bdcf3476d1a6fc113cd00e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg?locale=de)
3 Streaming Stocks That Can Push Past the Actors Guild Strike
The current screen actors guild (SAG AFTRA) strike is not being felt by consumers yet. With several blockbuster movies already finished production, there should be a steady stream of content for
![3 Streaming Stocks That Can Push Past the Actors Guild Strike: https://www.marketbeat.com/logos/articles/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTlmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db0844dcd7b6675055bdcf3476d1a6fc113cd00e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg?locale=de)
3 Streaming Stocks That Can Push Past the Actors Guild Strike
The current screen actors guild (SAG AFTRA) strike is not being felt by consumers yet. With several blockbuster movies already finished production, there should be a steady stream of content for
![3 Streaming Stocks That Can Push Past the Actors Guild Strike: https://www.marketbeat.com/logos/articles/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTlmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db0844dcd7b6675055bdcf3476d1a6fc113cd00e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728074800_3-streaming-stocks-that-can-push-past-the-actors-g.jpg?locale=de)
3 Streaming Stocks That Can Push Past the Actors Guild Strike
The current screen actors guild (SAG AFTRA) strike is not being felt by consumers yet. With several blockbuster movies already finished production, there should be a steady stream of content for
![The Road Ahead For UPS: Can Stock Deliver After Contract Deal?: https://www.marketbeat.com/logos/articles/med_20230728073748_the-road-ahead-for-ups-can-stock-deliver-after-con.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenBmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--24eb22e42df8106f671cf3d48c6556b1824a5bf8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230728073748_the-road-ahead-for-ups-can-stock-deliver-after-con.jpg?locale=de)
The Road Ahead For UPS: Can Stock Deliver After Contract Deal?
What’s next for United Parcel Service Inc. (NYSE: UPS) stock after management and the Teamsters union came to an agreement on a new contract, averting a strike?
Judging by the stock’s price
![The Patent Cliff Is Why AbbVie Is Moving Higher: https://www.marketbeat.com/logos/articles/med_20230727111439_chart-abbv-7272023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHBmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--935cca24a6778feef68acd0ba705fc302dbc20e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230727111439_chart-abbv-7272023.png?locale=de)
The Patent Cliff Is Why AbbVie Is Moving Higher
AbbVie (NYSE: ABBV) shares have been under pressure for the last 2 years as fears of the patent cliff gripped the market. The fear of rapidly declining Humira sales was not offset by hope driven by
![Is It Time To Start Buying Southwest Airlines' Post-Earnings Dip?: https://www.marketbeat.com/logos/articles/med_20230727124806_is-it-time-to-start-buying-southwest-airlines-post.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3RlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--22c33150fb86c7131ff99f3db2dc7fb86eb2f8a8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230727124806_is-it-time-to-start-buying-southwest-airlines-post.jpg?locale=de)
Is It Time To Start Buying Southwest Airlines' Post-Earnings Dip?
Shares of Southwest Airlines (NYSE: LUV) are traded lower by as much as 9.0% during Thursday's trading session, a reaction that seems an exaggeration following the company's second quarter 2023
![7 Best Cancer Stocks to Invest in Now: https://www.marketbeat.com/logos/articles/med_20230727124720_screen-shot-2023-07-27-at-124639-pm.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3hlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--58b3da07e718bdee0eb4b30bfa9d8433ea4cb2d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230727124720_screen-shot-2023-07-27-at-124639-pm.png?locale=de)
7 Best Cancer Stocks to Invest in Now
One of the most aggressive and difficult-to-treat ailments, cancer is a disease that involves the uncontrolled division and growth of malignant cells. There are many types of cancer, many of which
![7 Best Cancer Stocks to Invest in Now: https://www.marketbeat.com/logos/articles/med_20230727124720_screen-shot-2023-07-27-at-124639-pm.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3hlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--58b3da07e718bdee0eb4b30bfa9d8433ea4cb2d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230727124720_screen-shot-2023-07-27-at-124639-pm.png?locale=de)
7 Best Cancer Stocks to Invest in Now
One of the most aggressive and difficult-to-treat ailments, cancer is a disease that involves the uncontrolled division and growth of malignant cells. There are many types of cancer, many of which
![Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB) Jetzt 198%: https://www.irw-press.at/prcom/images/messages/2023/71465/AC-280723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1JlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bc1e7c899e0066a6c547502bd6bd98db789982b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-280723.001.png?locale=de)
Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB) Jetzt 198%
Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. 198% Biotech Hot Stock nach 134.452% mit Biogen
28.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB) Jetzt 198%: https://www.irw-press.at/prcom/images/messages/2023/71465/AC-280723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1JlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bc1e7c899e0066a6c547502bd6bd98db789982b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-280723.001.png?locale=de)
Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. Massives Kaufsignal. Neuer 198% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB) Jetzt 198%
Eilt: Bahnbrechende Investitionen in Kürze - Krebs vollständig geheilt. 198% Biotech Hot Stock nach 134.452% mit Biogen
28.07.23 08:02
London (www.aktiencheck.de , Anzeige)